Study Design: Retrospective review of prospective registries.

Objectives: We hypothesized that patients with congenitally fused ribs who underwent thoracostomy upon implantation of rib-based distraction devices would achieve improved spine growth compared with those who did not undergo thoracostomy.

Summary Of Background Data: Patients with fused ribs may develop thoracic insufficiency syndrome. Treatment for severe early-onset spinal deformity with rib fusions often includes the placement of rib-based expansion devices with surgical division of the fused ribs (thoracostomy). The effect of thoracostomy on spinal growth has not been fully examined.

Methods: Two multicenter registries of primarily prospectively collected data were searched. Patients with fused ribs and implantation of a rib-based device were identified. A total of 151 patients with rib fusions treated with rib-based constructs and minimum two-year follow-up were included. Among those, 103 patients were treated with expansion thoracostomy at the time of implantation, whereas 48 patients received device implantation alone. We evaluated change in T1-T12 and T1-S1 height, coronal Cobb angle, kyphosis, and number of surgeries. Preoperative deformity was similar between the two groups. Only 19% of patient underwent final fusion, with similar numbers fused in each group.

Results: At latest follow-up, the expansion thoracostomy group had a greater total improvement in T1-S1 height (7.2 cm vs. 4.8 cm, p = .004). There was no difference between the two groups for change in spinal height at each lengthening procedure. Interestingly, thoracostomy patients also underwent more total surgeries (11.5 vs. 9.6, p = .031) and more lengthening procedures (8.3 vs. 6.6, p = .017) than the comparison group despite similar length of follow-up.

Conclusions: Patients who underwent expansion thoracostomy at the time of rib expansion device implantation achieved greater improvement in T1-S1 height than those who underwent implantation of rib expansion device alone. Further work is needed to evaluate whether expansion thoracostomy impacts pulmonary function.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jspd.2019.01.004DOI Listing

Publication Analysis

Top Keywords

expansion thoracostomy
20
fused ribs
20
t1-s1 height
12
patients
9
expansion
8
spine growth
8
treated rib-based
8
thoracostomy
8
implantation rib-based
8
patients fused
8

Similar Publications

Article Synopsis
  • Prevotella species are typically harmless bacteria found in the intestines and mouth but can cause infections in immune-compromised individuals.
  • A 35-year-old man presented with high fever and chest pain, showing signs of an infection with severe respiratory symptoms and poor oral hygiene.
  • After medical imaging revealed a loculated pyopneumothorax, a chest tube was inserted, draining foul-smelling pus that tested positive for Prevotella Intermediata, which responded well to treatment.
View Article and Find Full Text PDF
Article Synopsis
  • Thoracostomy and chest tube placement are essential procedures for managing pleural diseases caused by fluid or air buildup in the pleural cavity, with historic methods evolving significantly since Hippocrates.
  • The development of closed drainage systems in the 19th century and advancements in materials, such as plastic and the Heimlich valve, have improved chest tube designs and functionality.
  • Modern techniques include various tube designs, digital monitoring systems, and the use of pleurodesis to prevent complications, ensuring that chest tube insertion continues to play a vital role in treating pleural conditions effectively.
View Article and Find Full Text PDF
Article Synopsis
  • Tube thoracostomy (TT) is used to drain fluid from the pleural cavity, but improper tube positioning occurs in 30% of cases, which can complicate treatment.* -
  • In a study involving 650 TT procedures on cadaver torsos, two techniques ("head" vs. "bed" direction) were compared to see which resulted in fewer instances of tube placement in lung fissures.* -
  • Results showed that tubes aimed "toward the bed" had a significantly lower placement rate in fissures (13%) compared to the "head" positioning (41%), suggesting that this technique could improve clinical outcomes.*
View Article and Find Full Text PDF
Article Synopsis
  • Recurrent pneumothorax (rPTX) is a common issue after removing thoracostomy tubes in chest trauma patients, and traditional chest X-rays (CXR) are used to detect it, but bedside ultrasound (UPUS) offers a low-cost, radiation-free alternative.
  • A study with 92 patients aimed to determine the best timing for UPUS after tube removal, revealing that ultrasound performed at 3 hours post-removal had the highest sensitivity for detecting clinically concerning rPTX.
  • The findings suggest that rPTX size stabilizes by 4 hours, indicating that if no symptoms are present, further imaging beyond this timeframe may not be necessary.*
View Article and Find Full Text PDF

Background: The current discourse within the thoracic surgical and pulmonological communities pertains to a contentious debate over the optimal selection criteria for thoracostomy tube diameters utilized in the management of pleural effusions. A comprehensive examination of the variables that inform the clinical decision-making paradigm for the determination of appropriate chest tube calibers is imperative to enhance patient management and elevate the prognostic results.

Objectives: The objective of this inquiry is to elucidate the determinants that influence thoracic surgeons and pulmonologists in their selection of chest tube size for the management of pleural effusions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!